Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Current therapies in dementia].

Hiroyuki Arai1

  • 1Department of Geriatric and Complementary Medicine, Advanced Research Center for Asian Traditional Medicine, Tohoku University, Graduate School of Medicine.

Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics
|July 9, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hippocampal Blood Flow Abnormality Associated With Depressive Symptoms and Cognitive Impairment in Patients With Chronic Heart Failure.

Circulation journal : official journal of the Japanese Circulation Society·2016
Same author

[Introduction].

Nihon rinsho. Japanese journal of clinical medicine·2016
Same author

[The trend of developing new disease-modifying drugs in Alzheimer's disease].

Nihon rinsho. Japanese journal of clinical medicine·2016
Same author

[What we did and learnt in the care of the patients with dementia after the Great East Japan Earthquake in 2011].

Nihon rinsho. Japanese journal of clinical medicine·2016
Same author

Differential effects of docoosahexaenoic and arachidonic acid on fatty acid composition and myosin heavy chain-related genes of slow- and fast-twitch skeletal muscle tissues.

Molecular and cellular biochemistry·2016
Same author

Introduction and overview of the special issue "Brain imaging and aging": The new era of neuroimaging in aging research.

Ageing research reviews·2016

Cholinergic therapies, like cholinesterase inhibitors, are effective for Alzheimer's disease (AD). These treatments increase acetylcholine availability, improving cognitive and global functions in AD patients.

Area of Science:

  • Neuroscience
  • Pharmacology

Context:

  • Alzheimer's disease (AD) involves damage to cholinergic neurons.
  • Loss of cholinergic activity correlates with cognitive decline in AD.

Purpose:

  • To review the efficacy of current cholinergic therapies for Alzheimer's disease.
  • To highlight the role of cholinesterase inhibitors in managing AD symptoms.

Summary:

  • Cholinergic therapies, particularly cholinesterase inhibitors (e.g., donepezil, galantamine, rivastigmine), are recommended for mild to moderate AD.
  • These drugs enhance acetylcholine levels, showing benefits in cognitive and global functions.
  • Donepezil is effective and safe, even in elderly patients (85+).
  • Herbal medicines like kami-untan-to and hachimi-jiou-gan show preliminary promise.

Related Experiment Videos

Impact:

  • Cholinergic therapies are a first-line treatment for AD according to the American Academy of Neurology.
  • Established efficacy of donepezil across major international trials.
  • Need for expanded therapeutic options to broaden treatment windows for AD.